IRIS
TONON, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.477
AS - Asia 3.803
EU - Europa 3.213
SA - Sud America 1.373
OC - Oceania 194
AF - Africa 77
Continente sconosciuto - Info sul continente non disponibili 4
Totale 13.141
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.169
SG - Singapore 1.421
BR - Brasile 1.145
CN - Cina 1.028
HK - Hong Kong 642
IT - Italia 561
SE - Svezia 460
GB - Regno Unito 389
RO - Romania 327
DE - Germania 323
VN - Vietnam 322
CA - Canada 222
AU - Australia 193
RU - Federazione Russa 175
AT - Austria 114
AR - Argentina 109
JP - Giappone 95
FR - Francia 94
FI - Finlandia 90
NL - Olanda 89
PL - Polonia 78
MX - Messico 73
IN - India 72
CH - Svizzera 71
CZ - Repubblica Ceca 65
ES - Italia 64
LT - Lituania 60
BD - Bangladesh 44
EC - Ecuador 43
ZA - Sudafrica 42
NO - Norvegia 37
ID - Indonesia 36
AL - Albania 34
DK - Danimarca 31
TR - Turchia 31
UA - Ucraina 27
BE - Belgio 24
EE - Estonia 24
IQ - Iraq 22
RS - Serbia 22
IE - Irlanda 20
CO - Colombia 19
PY - Paraguay 18
PK - Pakistan 15
CL - Cile 14
MA - Marocco 14
VE - Venezuela 14
UZ - Uzbekistan 11
GR - Grecia 10
AE - Emirati Arabi Uniti 7
SA - Arabia Saudita 7
DO - Repubblica Dominicana 6
CM - Camerun 5
MY - Malesia 5
TW - Taiwan 5
AZ - Azerbaigian 4
BG - Bulgaria 4
IR - Iran 4
MK - Macedonia 4
PE - Perù 4
PS - Palestinian Territory 4
UY - Uruguay 4
BH - Bahrain 3
BN - Brunei Darussalam 3
CY - Cipro 3
DZ - Algeria 3
EG - Egitto 3
LB - Libano 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
BO - Bolivia 2
BW - Botswana 2
GD - Grenada 2
HN - Honduras 2
HU - Ungheria 2
IL - Israele 2
KE - Kenya 2
KR - Corea 2
KZ - Kazakistan 2
LV - Lettonia 2
NP - Nepal 2
PH - Filippine 2
SX - ???statistics.table.value.countryCode.SX??? 2
TN - Tunisia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
GY - Guiana 1
IM - Isola di Man 1
IS - Islanda 1
JO - Giordania 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
ME - Montenegro 1
MN - Mongolia 1
Totale 13.135
Salva come PNG Salva come JPEG
Città #
Dallas 1.524
Singapore 656
Hong Kong 641
Ashburn 435
Los Angeles 263
Hefei 232
Shanghai 225
Milan 192
London 181
Sydney 175
New York 142
Beijing 138
Lawrence 137
Princeton 137
São Paulo 134
Ho Chi Minh City 125
Montreal 125
Frankfurt am Main 114
Nuremberg 86
Moscow 81
Tokyo 77
Warsaw 71
Vienna 67
Prague 64
Stockholm 64
Buffalo 62
Toronto 59
Hanoi 58
Amsterdam 57
Paris 57
Orem 56
Helsinki 55
Zurich 46
Acalanes Ridge 44
Rio de Janeiro 42
Santa Clara 40
Piscataway 36
Waterbury 35
Boardman 34
Mexico City 33
Tirana 32
Copenhagen 31
Madrid 30
Munich 30
Oslo 28
Poplar 28
Phoenix 27
Washington 27
Lombard 26
Rome 26
Charlotte 25
Chennai 25
Houston 25
Brussels 24
Tallinn 24
Turku 23
Atlanta 22
Belgrade 22
Curitiba 22
Edison 22
Johannesburg 22
Brooklyn 21
Denver 21
Guangzhou 21
Dublin 20
Guayaquil 20
Buenos Aires 19
Segrate 19
Bern 18
Boston 18
The Dalles 18
Bucharest 17
Sao Paulo 17
Falkenstein 16
Haiphong 16
Seattle 16
Chicago 15
Fortaleza 15
Goiânia 15
Manaus 15
Manchester 15
Belo Horizonte 14
Brasília 14
Brisbane 14
Guarulhos 14
Kyiv 14
Baltimore 13
Cesano Boscone 13
Abbeville 12
Tianjin 12
Brescia 11
Campinas 11
Da Nang 11
Lappeenranta 11
Miami 11
Porto Alegre 11
San Francisco 11
Ankara 10
Athens 10
Columbus 10
Totale 7.920
Salva come PNG Salva come JPEG
Nome #
The 1+Million Genomes Minimal Dataset for Cancer 4.065
Revealing and harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells 126
In vivo macrophage engineering reshapes the tumor microenvironment leading to eradication of liver metastases 124
Aging, inflammation and DNA damage in the somatic testicular niche with idiopathic germ cell aplasia 105
Chromatin Velocity reveals epigenetic dynamics by single-cell profiling of heterochromatin and euchromatin 101
A NOVEL MODEL INTEGRATING CLINICAL, MP-MRI, AND EPIGENOMIC FEATURES TO PREDICT LYMPH NODE INVASION IN PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY AND PELVIC LYMPH NODE DISSECTION 99
Systemic delivery of cadherin 17–specific CAR T cells allows effective and safe targeting of colorectal cancer liver metastases 92
Radiomic and gEnomic approaches for the enhanced DIagnosis of clear cell REnal Cancer (REDIRECt): a translational pilot methodological study 84
Direct stimulation of ERBB2 highlights a novel cytostatic signaling pathway driven by the receptor Thr701 phosphorylation 80
Alternative BCR/ABL splice variants in Philadelphia chromosome-positive leukemias result in novel tumor-specific fusion proteins that may represent potential targets for immunotherapy approaches. 79
A whole-genome sequencing study associates GRAMD1B with multiple sclerosis risk and disease activity 79
Global transcriptomic changes occur in uterine fluid-derived extracellular vesicles during the endometrial window for embryo implantation 76
NON-GENOMIC ALTERATIONS IN ANTIGEN PRESENTATION AND T CELL COSTIMULATION ARE DISTINCT DRIVERS OF LEUKEMIA IMMUNE ESCAPE AND RELAPSE AFTER HEMATOPOIETIC CELL TRANSPLANTATION 72
Germline testing and genetic counseling in biliary tract cancer: an operative proposal to improve the state of art 72
A federated learning system for precision oncology in Europe: DigiONE 70
HIF-1α regulates the interaction of chronic lymphocytic leukemia cells with the tumor microenvironment 68
A compendium of DIS3 mutations and associated transcriptional signatures in plasma cell dyscrasias 67
Iron increases the susceptibility of multiple myeloma cells to bortezomib 66
N-Glycosylation Inhibition Hinders Immunosuppressive Activity of Tumor Microenvironment Cells and Improves CAR T Cell Efficacy 66
Analyzing genomic and epigenetic profiles in single cells by hybrid transposase (scGET-seq) 65
A study of MECT1-MAML2 in mucoepidermoid carcinoma and Warthin's tumor of salivary glands 64
Omics Sciences in Drug Discovery, Safety, and Pharmacokinetics 63
Pre-existing immunity drives the response to neoadjuvant chemotherapy in esophageal adenocarcinoma 61
ATR addiction in Multiple Myeloma: synthetic lethal approaches exploiting established therapies 61
Lentiviral vector-based insertional mutagenesis identifies genes associated with liver cancer 61
A next generation sequencing study in Italian multiplex families with multiple sclerosis 61
ASSOCIATION BETWEEN BRCA 1/2 POLYMORPHISMS AND DISEASE AGGRESSIVENESS IN A PROSPECTIVE COHORT OF PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY 61
ASSOCIATION BETWEEN RS6152 POLYMORPHISM IN THE ANDROGEN RECEPTOR GENE AND DISEASE AGGRESSIVENESS IN A PROSPECTIVE COHORT OF PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY 60
Author Correction: Direct stimulation of ERBB2 highlights a novel cytostatic signaling pathway driven by the receptor Thr701 phosphorylation (Scientific Reports, (2020), 10, 1, (16906), 10.1038/s41598-020-73835-1) 60
Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation 58
An Oncogene-Regulated Epigenetic Switch in T Cell Acute Lymphoblastic Leukemia 58
Harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells 58
A whole-genome epigenomic approach in multiple sclerosis multiplex families revealed new epigenetic traits involved in the disease 57
HARNESSING CD39 FOR THE TREATMENT OF COLORECTAL CANCER AND LIVER METASTASES BY ENGINEERED T CELLS 57
ASSOCIATION BETWEEN POLYMORPHISMS OF HOMOLOGOUS RECOMBINATION RAD51B AND DISEASE RECURRENCE IN A PROSPECTIVE COHORT OF PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY 56
Harnessing CD39 for the Treatment of Colorectal Cancer and Liver Metastases by Engineered T Cells 56
A "static" karyotype in epithelial cancer cell lines despite ongoing chromsomal instability 56
A "static" karyotype in epithelial cancer cell lines despite ongoing chromosomal instability 55
Chest CT in the emergency department for suspected COVID-19 pneumonia 55
Longitudinal analysis of T cell receptor repertoires reveals shared patterns of antigen-specific response to SARS-CoV-2 infection 54
Modeling Multiple Myeloma-Bone Marrow interactions and response to drugs in a 3D surrogate microenvironment 53
Extracellular vesicles secreted by human aneuploid embryos present a distinct transcriptomic profile and upregulate MUC1 transcription in decidualised endometrial stromal cells 52
Whole-genome epigenomic approach in multiplex families with multiple sclerosis revealed new epigenetic traits involved in the disease 51
Microbiota-driven interleukin-17-producing cells and eosinophils synergize to accelerate multiple myeloma progression 51
ATR addiction in multiple myeloma: synthetic lethal approaches exploiting established therapies 50
RADIOMIC AND GENOMIC APPROACHES FOR THE ENHANCED DIAGNOSIS OF RENAL CANCER (REDIRECT): A TRANSLATIONAL PILOT STUDY 50
Rete IDEA: solving the unsolved diagnoses of primary immunodeficiency 50
CS1, a new surface target on multiple myeloma (MM) cells, protects myeloma cells from apoptosis via-regulation of ERKI/2, AKT and STAT3 signaling cascades 50
Angiogenesis Associated with Alterations of the Bone Marrow Microenvironment Predicts Multiple Myeloma Progression to Symptomatic Disease in Mice and Humans 50
Correction of ß-thalassemia major by gene transfer in hematopoietic progenitors of pediatric patients 49
PROFILING THE MUTATIONAL LANDSCAPE OF ACUTE MYELOID LEUKEMIA AT RELAPSE AFTER CHEMOTHERAPY AND ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION 49
IFNalpha by In Vivo-Engineered Macrophages Abates Liver Metastases and Triggers Counter Regulatory Responses Limiting Efficacy 48
Profiling the Genomic Landscape at the Early Stages of CLL: Low Genomic Complexity and Paucity of Driver Mutations in MBL and Indolent CLL 48
Genomics in Multiple Myeloma: From Conventional Cytogenetics to Novel Whole-Genome Sequencing Approaches 48
Loss of ribonuclease DIS3 hampers genome integrity in myeloma by disrupting DNA:RNA hybrid metabolism 47
Pathological glycogenesis through glycogen synthase 1 and suppression of excessive AMP kinase activity in myeloid leukemia cells 47
Somatic mutations affect key pathways in lung adenocarcinoma 47
UNCAN.eu: Toward a European Federated Cancer Research Data Hub 46
Th22 cells increase in poor prognosis multiple myeloma and promote tumor cell growth and survival 46
Tumor suppressor PNRC1 blocks rRNA maturation by recruiting the decapping complex to the nucleolus 46
Karyotypic complexity of the NCI-60 drug-screening panel. 46
Identification of new human liver cancer genes by a novel lentiviral vector-based insertional mutagenesis approach in three mouse models of hepatocarcinogenesis 45
Deletion of a pseudogene within a fragile site triggers the oncogenic expression of the mitotic CCSER1 gene 45
The WNT receptor ROR2 drives the interaction of multiple myeloma cells with the microenvironment through AKT activation 44
Neutralising reactivity against SARS-CoV-2 Delta and Omicron variants by vaccination and infection history 44
A Whole-Exome Sequencing Study In Multiple Sclerosis Multiplex Families 44
Chromogranin A is preferentially cleaved into pro-angiogenic peptides in the bone marrow of multiple myeloma patients 44
Multiple reciprocal translocations in salivary gland mucoepidermoid carcinomas 44
Identification of a truncated ADP-activated P-2X1 receptor in platelets and megakaryocytic cell lines 44
RNA sequencing of blood from sex- and age-matched discordant siblings supports immune and transcriptional dysregulation in autism spectrum disorder 43
Awakening the Hippo co-activator YAP1, a mercurial cancer gene, in hematologic cancers 43
β-arrestin1/YAP/mutant p53 complexes orchestrate the endothelin A receptor signaling in high-grade serous ovarian cancer 42
Novel Therapeutic Targets in Multiple Myeloma 42
FAM46C and FNDC3A Are Multiple Myeloma Tumor Suppressors That Act in Concert to Impair Clearing of Protein Aggregates and Autophagy 41
A whole-exome sequencing approach in multiplex Italian multiple sclerosis families to identify new genes involved in the disease 41
High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients 41
Disentangling the microRNA regulatory milieu in multiple myeloma: integrative genomics analysis outlines mixed miRNA-TF circuits and pathway-derived networks modulated in t(4;14) patients 41
Weak platelet agonists and U46619 induce apoptosis-like events in platelets, in the absence of phosphatidylserine exposure. 41
C-Myc- Dependent Stabilization of Hif-1alpha in MM: Therapeutic Implications 41
DNA methylation alterations in prostate cancer: from diagnosis to treatment 40
Common and contrasting genomic profiles among the major human lung cancer subtypes 40
Che-1-induced inhibition of mTOR pathway enables stress-induced autophagy 40
Early onset sporadic colorectal cancer: Worrisome trends and oncogenic features 40
t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway 40
Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets 40
In vitro and in vivo activity of the VEGF inhibitor pazopanib 40
Towards cross-border access to human genomes and clinical information at scale for research and healthcare 39
H3K4me3 demethylation by the histone demethylase KDM5C/JARID1C promotes DNA replication origin firing 39
Expression of apoptotic markers in activated platelets is mediated in part by cathepsin 39
IFNalpha by in vivo-engineered macrophages abates liver metastases and triggers counter regulatory responses limiting efficacy 38
JunB/AP-1 controls MM cell proliferation, survival and drug resistance in the bone marrow microenvironment 38
Loss of the histone demethylase UTX alters the gene expression prolife and contributes to the malignant phenotype of multiple myeloma cells 38
Telomere dysfunction induces metabolic and mitochondrial compromise. 38
Synthetic Lethal Approaches to Exploit Replicative Stress in Aggressive Myeloma 38
Identification of alternative forms of a P2X(1) receptor in platelets and megakaryocytic cells. 38
Serine/Threonine Kinase STK4 Is a Novel Target in Myeloma 38
INHIBITION OF THE STK4 KINASE RESTORES THE HIPPO CO-FACTOR YAP1 AND INDUCES DNA-DAMAGE MEDIATED APOPTOSIS IN MULTIPLE MYELOMA CELLS 38
Genetic distance, transportation costs, and trade 38
Rescue of Hippo coactivator YAP1 triggers DNA damage-induced apoptosis in hematological cancers 37
Highly similar genomic landscapes in monoclonal b-cell lymphocytosis and ultra-stable chronic lymphocytic leukemia with low frequency of driver mutations 37
Totale 9.435
Salva come PNG Salva come JPEG
Categoria #
all - tutte 72.869
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.869
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20219 0 0 0 0 0 4 5 0 0 0 0 0
2021/2022156 0 0 0 12 2 0 2 121 2 11 1 5
2022/2023800 287 178 31 7 48 114 33 59 15 8 13 7
2023/2024433 10 14 47 124 30 53 15 29 1 25 23 62
2024/20256.214 250 59 88 123 112 261 739 365 505 2.699 761 252
2025/20265.809 745 945 1.605 1.443 755 316 0 0 0 0 0 0
Totale 13.439